Profitability
Weight: 25%
F
12
- 5yr Avg ROIC 1.5%
- Operating Margin Trend -4.35 pp/yr
PCRX
Pacira BioSciences, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
F
26
- 5yr Avg ROE 0.2%
- 5yr Share-Count CAGR 0.6%
Growth Quality
Weight: 25%
C+
57
- 5yr Revenue CAGR 11.1%
- 5yr EPS CAGR -45.5%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
B+
78
- 5yr FCF Margin 19.4%
- 5yr FCF/NI Conversion 7.97x
Balance Sheet
Weight: 10%
C
55
- Net Debt / EBITDA 1.76x
- Interest Coverage (EBIT/Int) 2.16x
- Altman Z-Score 2.34
Stability
Weight: 5%
C
52
- EPS Volatility (σ/μ) 1.29
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 8
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 2 trimmed.
- Holders
- 2
- Avg Δ position
- -19.4%
- New buys
- 0
- Full exits
- 0
- Greenblatt decreased -37%
- Cooperman decreased -2%